Mobile Carbapenemase Genes in Pseudomonas aeruginosa

EJ Yoon, SH Jeong - Frontiers in microbiology, 2021 - frontiersin.org
Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical
settings impelling a great challenge to antimicrobial therapy for patients with infections …

Update on the epidemiology of carbapenemases in Latin America and the Caribbean

JC García-Betancur, TM Appel, G Esparza… - Expert review of anti …, 2021 - Taylor & Francis
Introduction Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam
antibiotics, including carbapenems. Carbapenemase production in Enterobacterales …

Antibacterial effect of cerium oxide nanoparticle against Pseudomonas aeruginosa

K Zamani, N Allah-Bakhshi, F Akhavan, M Yousefi… - BMC …, 2021 - Springer
Background Antibiotics have been widely used for the treatment of bacterial infections for
decades. However, the rapid emergence of antibiotic-resistant bacteria has created many …

[HTML][HTML] Insight into phylogenomic bias of blaVIM-2 or blaNDM-1 dissemination amongst carbapenem-resistant Pseudomonas aeruginosa

G Fortunato, I Vaz-Moreira, I Gajic… - International Journal of …, 2023 - Elsevier
Objectives Pseudomonas aeruginosa (P. aeruginosa) are ubiquitous opportunistic
pathogens that combine intrinsic and acquired multidrug resistance phenotypes. Due to …

Worldwide Dissemination of blaKPC Gene by Novel Mobilization Platforms in Pseudomonas aeruginosa: A Systematic Review

D Forero-Hurtado, ZL Corredor-Rozo… - Antibiotics, 2023 - mdpi.com
The dissemination of bla KPC-harboring Pseudomonas aeruginosa (KPC-Pa) is considered
a serious public health problem. This study provides an overview of the epidemiology of …

Remotely Controllable Engineered Bacteria for Targeted Therapy of Pseudomonas aeruginosa Infection

Y Gao, J Wei, L Pu, S Fu, X Xing, R Zhang… - ACS Synthetic …, 2023 - ACS Publications
Pseudomonas aeruginosa (P. aeruginosa) infection has become an intractable problem
worldwide due to the decreasing efficacy of the mainstay therapy, antibiotic treatment …

Genetic Diversity of Multidrug-Resistant Pseudomonas aeruginosa Isolates Carrying blaVIM–2 and blaKPC–2 Genes That Spread on Different Genetic …

AM Rada, E De La Cadena, CA Agudelo… - Frontiers in …, 2021 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic Gram-negative pathogen with an increase in
the frequency of infections caused by multidrug resistant (MDR) and extensively drug …

Emerging and re-emerging KPC-producing hypervirulent Pseudomonas aeruginosa ST697 and ST463 between 2010 and 2021

B Zhang, X Xu, X Song, Y Wen, Z Zhu, J Lv… - Emerging microbes & …, 2022 - Taylor & Francis
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) has been a major threat to human
health due to its increased morbidity and mortality in clinical settings. Carbapenemase …

[HTML][HTML] Nosocomial infections by diverse carbapenemase-producing Aeromonas hydrophila associated with combination of plumbing issues and heat waves

HK Gray, A Bisht, JR Caldera, NMF Braegger… - American Journal of …, 2024 - Elsevier
Background Aquatic opportunistic pathogen Aeromonas hydrophila, known to persist in low-
nutrient chlorinated waters, can cause life-threatening infections. Two intensive care units …

KPC-2-producing Pseudomonas aeruginosa isolated from wild animals in Brazil

J dos Santos Costa, PB Dos Santos… - Brazilian Journal of …, 2023 - Springer
Pseudomonas aeruginosa an opportunistic pathogen that causes infections in hospitals and
has high morbidity and mortality rates. In addition, it is a widely distributed environmental …